Literature DB >> 17698398

Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.

Ping Feng1, Bei Wang, Ee Chee Ren.   

Abstract

Cyr61/CCN1 is a secreted extracellular matrix associated protein involved in diverse biological functions and plays multiple roles in tumorigenesis. Cyr61 was down-regulated in HCC tumor tissues as observed in our previous cDNA microarray study, but its potential role in hepatocarcinogenesis is still unclear. To explore the biological significance of Cyr61 in HCC development, over-expression of this gene was established in HCC cell lines and its effects on cell proliferation, adhesion, migration and invasion were analyzed in this study. Cyr61 expression was down-regulated in HCC tumors as measured by quantitative real-time PCR and its protein level was decreased in most HCC cell lines as detected by Western blot. Over-expression of Cyr61 in HCC cell lines suppressed cell proliferation in monolayer and anchorage-independent growth in soft agar, whereas down-regulation of Cyr61 by siRNA increased cell proliferation rate. Over-expression of Cyr61 also significantly enhanced adhesion activities of HepG2 cells to various ECM proteins. Moreover, stably transfected HepG2-Cyr61 cells showed inhibited cell mobility (40-45%) and reduced invasiveness (30-40%) compared to HepG2-Neo controls. Furthermore, upon exposure to 5-Fluorouracil and UV irradiation, Cyr61 was rapidly induced in both p53(+/+) HepG2 and p53(-/-) Hep3B cells. However, only HepG2 cells showed increased G2/M phase arrest with concomitant up-regulation in p53 and p21 levels, suggesting that Cyr61 may play an active role in regulating HCC cell growth involving p53 as well as alternative pathways. In conclusion, we demonstrated that Cyr61 is a tumor suppressor in hepatocarcinogenesis and is involved in DNA damage response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698398     DOI: 10.1016/j.biocel.2007.06.020

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  27 in total

1.  Extracellular matrix associated protein CYR61 is linked to prostate cancer development.

Authors:  Katherine B D'Antonio; Antoun Toubaji; Roula Albadine; Alison M Mondul; Elizabeth A Platz; George J Netto; Robert H Getzenberg
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

2.  Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction.

Authors:  Zhengfa Mao; Xiaoyan Ma; Xin Fan; Lei Cui; Ting Zhu; Jianguo Qu; Jianxin Zhang; Xuqing Wang
Journal:  Tumour Biol       Date:  2014-07-16

Review 3.  CCN1/CYR61: the very model of a modern matricellular protein.

Authors:  Lester F Lau
Journal:  Cell Mol Life Sci       Date:  2011-07-31       Impact factor: 9.261

4.  Molecular signatures for CCN1, p21 and p27 in progressive mantle cell lymphoma.

Authors:  Afak Rasheed Salman Zaidi; Sadie Dresman; Charlotte Burt; Simon Rule; Lynn McCallum
Journal:  J Cell Commun Signal       Date:  2018-11-21       Impact factor: 5.782

5.  Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.

Authors:  Y F Song; Z B Xu; X J Zhu; X Tao; J L Liu; F L Gao; C L Wu; B Song; Q Lin
Journal:  Clin Transl Oncol       Date:  2016-10-14       Impact factor: 3.405

Review 6.  Cyr61 is a potential prognostic marker for prostate cancer.

Authors:  Naoki Terada; Prakash Kulkarni; Robert H Getzenberg
Journal:  Asian J Androl       Date:  2012-02-20       Impact factor: 3.285

7.  Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.

Authors:  Katherine B D'Antonio; Lucianna Schultz; Roula Albadine; Alison M Mondul; Elizabeth A Platz; George J Netto; Robert H Getzenberg
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

8.  Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.

Authors:  Naoki Terada; Takumi Shiraishi; Yu Zeng; Steven M Mooney; David B Yeater; Leslie A Mangold; Alan W Partin; Prakash Kulkarni; Robert H Getzenberg
Journal:  Prostate       Date:  2011-10-24       Impact factor: 4.104

9.  CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.

Authors:  Xuqing Wang; Yuezhen Deng; Zhengfa Mao; Xiaoyan Ma; Xin Fan; Lei Cui; Jianguo Qu; Dong Xie; Jianxin Zhang
Journal:  Tumour Biol       Date:  2012-07-03

10.  CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice.

Authors:  Zhaolian Bian; Yanshen Peng; Zhengrui You; Qixia Wang; Qi Miao; Yuan Liu; Xiaofeng Han; Dekai Qiu; Zhiping Li; Xiong Ma
Journal:  J Lipid Res       Date:  2012-10-15       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.